Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer

BACKGROUND: Progesterone receptor (PgR) negative breast cancer (BC) is an aggressive subtype with poor prognosis and reduced response to endocrine treatments. Several studies have suggested that androgen receptor (AR) expression is associated with a favorable tumor biology, longer recurrence free su...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagliaferri, Barbara, Quaquarini, Erica, Palumbo, Raffaella, Balletti, Emanuela, Presti, Daniele, Malovini, Alberto, Agozzino, Manuela, Teragni, Cristina Maria, Terzoni, Andrea, Bernardo, Antonio, Villani, Laura, Sottotetti, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502860/
https://www.ncbi.nlm.nih.gov/pubmed/32994808
http://dx.doi.org/10.1177/1758835920958355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502860/
https://www.ncbi.nlm.nih.gov/pubmed/32994808
http://dx.doi.org/10.1177/1758835920958355

Ejemplares similares